Digoxin and Didanosine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Digoxin (digoxin) and Didanosine (didanosine). Common drug interactions include fall among females and headache among males.

The phase IV clinical study analyzes what interactions people have when they take Digoxin and Didanosine. It is created by eHealthMe based on reports of 25 people who take the same drugs from the FDA, and is updated regularly.

What is Digoxin?

Digoxin has active ingredients of digoxin. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 93,740 Digoxin users. Check the latest studies of Digoxin.

What is Didanosine?

Didanosine has active ingredients of didanosine. It is often used in hiv infection. eHealthMe is studying from 7,446 Didanosine users. Check the latest studies of Didanosine.



On Jul, 09, 2026

25 people who take Digoxin and Didanosine together, and have interactions are studied.

Digoxin and Didanosine drug interactions.

What are the common drug interactions of Digoxin and Didanosine, by gender? *:

female:

  1. Fall
  2. Foetal exposure during pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect)
  3. Hypokalaemia (low potassium)
  4. Hypospadias (an abnormal condition in males in which the urethra opens on the under surface of the penis)
  5. Mitral valve incompetence (inefficient heart valve)
  6. Multiple injuries
  7. Musculoskeletal discomfort (discomfort in the body's muscles, joints, tendons, ligaments and nerves)
  8. Pulmonary arterial wedge pressure increased
  9. Renal failure (kidney dysfunction)
  10. Syncope (loss of consciousness with an inability to maintain postural tone)

male:

  1. Headache (pain in head)
  2. Hypertension (high blood pressure)
  3. Diarrhoea
  4. Hepatic failure (liver failure)
  5. Hyperglycaemia (high blood sugar)
  6. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  7. Pancreatitis (inflammation of pancreas)
  8. Pneumonia
  9. Thrombotic thrombocytopenic purpura (a rare blood disorder characterized by clotting in small blood vessels of the body)
  10. Hepatitis c

What are the common drug interactions of Digoxin and Didanosine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Cardiomyopathy (weakening of the heart muscle)

10-19:

  1. Cardiac disorder

20-29:

n/a

30-39:

n/a

40-49:

  1. Hepatitis c
  2. Bacteraemia (presence of bacteria in the blood)
  3. Body temperature increased
  4. Drug toxicity
  5. Endocarditis (inflammation in heart muscle)
  6. Hypertriglyceridaemia (excess of triglycerides in the blood)
  7. Hypocholesterolaemia (presence of abnormally small amounts of cholesterol in the circulating blood)
  8. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  9. Ocular icterus (presence of jaundice seen in the sclera of the eye)
  10. Pulmonary hypertension (increase in blood pressure in the lung artery)

50-59:

  1. Headache (pain in head)
  2. Hypertension (high blood pressure)
  3. Blood potassium increased
  4. Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it)
  5. Hepatic failure (liver failure)
  6. Hyperglycaemia (high blood sugar)
  7. Pancreatitis (inflammation of pancreas)
  8. Pneumonia
  9. Thrombotic thrombocytopenic purpura (a rare blood disorder characterized by clotting in small blood vessels of the body)
  10. Activated partial thromboplastin time prolonged

60+:

  1. Amylase increased
  2. Appendicitis (inflammation of the appendix)
  3. Herpes zoster
  4. Weight decreased
  5. Acute respiratory failure
  6. Anxiety
  7. Aortic stenosis (obstruction to the outflow of blood from the left ventricle into the aorta)
  8. Arrhythmia (irregular heartbeat)
  9. Blood calcium decreased
  10. Blood creatine increased

What are the existing conditions these people have? *

  1. Hiv Infection: 8 people, 32.00%
  2. Cardiac Failure: 4 people, 16.00%

* Approximation only. Some reports may have incomplete information.

Do you take Digoxin and Didanosine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Digoxin and Didanosine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Digoxin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Didanosine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Digoxin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Didanosine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on digoxin and didanosine (the active ingredients of Digoxin and Didanosine, respectively), and Digoxin and Didanosine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: